Comments
Pfizer scraps insulin deal with India's Biocon
13.03.2012. | MUMBAI (Reuters) - Pfizer Inc, the world's largest drugmaker, has scrapped a deal to sell insulin products made by Biocon Ltd, leaving India's biggest biotech company without a partner to sell the drugs in key global markets such as the United States....
